Mounjaro is approved to treat Type 2 diabetes in adults
Nello-Deakin 2024)
Depending on the value of the shape parameter , the upper limit of the 95% confidence interval (CI) for 1 demonstrates an increasing hazard over time (wear-out failure type), whereas the 95% CI includes 1 for , suggesting a constant hazard rate throughout the exposure period (random failure type)
This gradual titration is critical for minimizing gastrointestinal side effects such as nausea, vomiting, and diarrhea
These studies, funded by Novo Nordisk (the maker of Wegovy), showed the best results when the medication was combined with healthy eating and increased physical activity
These protective benefits have been observed in the GI tract, liver, cardiovascular system, and brain [20, 36]